Skip to main content
Bio Solution Co.,Ltd. logo

Bio Solution Co.,Ltd. — Investor Relations & Filings

Ticker · 086820 ISIN · KR7086820008 KO Manufacturing
Open in API
Filings indexed 214 across all filing types
Latest filing 2026-04-29 Regulatory Filings
Country KR South Korea
Listing KO 086820

About Bio Solution Co.,Ltd.

https://bio-solution.co.kr/

Bio Solution Co., Ltd. is a biotechnology company focused on the development, manufacturing, and sale of cell therapy products. The company's core activities involve cell-based biotechnology, producing therapeutics such as autologous chondrocyte treatments for cartilage regeneration. In addition to its therapeutic offerings, Bio Solution develops human tissue models and provides alternative testing solutions. The company also manufactures and distributes a portfolio of bio-laboratory products, including ready-to-use kits, staining solutions, and various reagents for molecular biology research and development applications.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Regulatory Filings Classification · 60% confidence The document is a regulatory announcement (filed to the Korea Exchange) notifying investors of an upcoming corporate IR (investor relations) presentation event, with details on date, time, format, and where the IR materials will be posted. It does not itself contain a presentation slide deck or detailed financial report, but is an event notice. This does not fit categories like 10-K, IR (interim report), ER (earnings release), or IP (which would be the slide deck itself). Therefore it is classified under the fallback category for miscellaneous regulatory filings: RNS.
2026-04-29 Korean
기업설명회(IR)개최
Investor Presentation Classification · 85% confidence The document is a formal announcement of a corporate investor relations presentation (IR) event, detailing date, time, format, agenda, sponsor, and where IR materials will be posted. It is not the actual financial report or presentation slides, nor a proxy, dividend notice, or earnings release. It fits best under the 'Investor Presentation' category as an IR event notice.
2026-04-17 Korean
기업설명회(IR)개최
Investor Presentation Classification · 80% confidence The document is an official notice in Korean of an upcoming corporate “Investor Relations (IR)” event (기업설명회), providing date, time, venue, participants, agenda, and related details. This is clearly an announcement around an investor presentation. Among the filing categories, “Investor Presentation (IP)” covers materials and notices for investors relating to strategy, financials, and corporate updates. Although this document announces the IR event rather than containing slide decks, it is best categorized as an Investor Presentation notice rather than a regular regulatory update or report. Therefore, the appropriate classification is IP.
2026-04-08 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a post-meeting announcement detailing the results of a regular (annual) shareholders’ general meeting, including vote outcomes for each resolution, election of outside directors, approval of financial statements, and related voting percentages. This matches the category for official declaration of voting results at a shareholder meeting.
2026-03-27 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 92% confidence The document is a formal notification of the appointment, dismissal, or mid-term resignation of an outside director (사외이사) at the company. This clearly pertains to changes in the company’s board composition, which falls under Board/Management Information. There is no indication this is an AGM presentation, earnings release, or other category.
2026-03-27 Korean
사업보고서 (2025.12)
Audit Report / Information Classification · 100% confidence The document is a comprehensive 'Audit Report' (감사보고서) for BioSolution, covering the fiscal year 2025. It includes the independent auditor's report, financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes. It is not an Annual Report (10-K) as it focuses specifically on the audit and financial statements rather than the broader business activity and management discussion typical of a full 10-K. It fits the definition of an Audit Report (AR). FY 2025
2026-03-19 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.